Do Direct-to-Consumer Drug Ads Do More Good Than Harm?
The Evidence Suggests a Ban on Ads May Not Be A Well-Targeted Solution
Population Health
Blog Post

It’s hard to put into words the impact of a pandemic that has upended nearly every aspect of our lives. But assessing that impact on patients, families, and communities is exactly what LDI Senior Fellow Mary Naylor and colleagues have done in a new discussion paper commissioned by the National Academy of Medicine. The paper provides a valuable perspective on the health consequences of the pandemic, the disproportionate effects on communities of color, and opportunities to transform our health system into one that can address the short- and longer-term challenges we face.
The paper, Patients, Families, and Communities COVID-19 Impact Assessment: Lessons Learned and Compelling Needs features quotes and stories of lived experiences to illustrate the wide-raging impact of the pandemic. Here’s just a sample of the paper’s findings, as summarized in two figures below. The paper is well worth a full read.


The discussion paper, Patients, Families, and Communities COVID-19 Impact Assessment: Lessons Learned and Compelling Needs, was published on November 29, 2021 by the National Academy of Medicine. Authors include Frederick Isasi, Mary D. Naylor, David Skorton, David C. Grabowski, Sandra Hernández, and Valerie Montgomery Rice.
The Evidence Suggests a Ban on Ads May Not Be A Well-Targeted Solution
Study of Six Large Language Models Found Big Differences in Responses to Clinical Scenarios
A Major Federal Value-Based Purchasing Program Was Designed to Cut Hospital Readmissions. LDI Fellows Say the Incentives Are Too Small to Drive Real Change
Penn LDI’s Antonia Villarruel and 10 Other Authors Map Social Determinants Across Multiple Racial and Ethnic Groups
Memo: Response to Request for Analysis
Lessons from the Past, Imperatives for the Future